Jane Street’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-182,457
| Closed | -$7.39M | – | 5356 |
|
|
2025
Q1 | $7.39M | Sell |
182,457
-42,562
| -19% | -$1.72M | ﹤0.01% | 1061 |
|
|
2024
Q4 | $6.26M | Buy |
225,019
+7,455
| +3% | +$207K | ﹤0.01% | 1003 |
|
|
2024
Q3 | $6.24M | Sell |
217,564
-39,970
| -16% | -$1.15M | ﹤0.01% | 1103 |
|
|
2024
Q2 | $6.04M | Buy |
257,534
+7,459
| +3% | +$175K | ﹤0.01% | 1497 |
|
|
2024
Q1 | $6.32M | Sell |
250,075
-5,474
| -2% | -$138K | ﹤0.01% | 1107 |
|
|
2023
Q4 | $5.97M | Buy |
255,549
+79,513
| +45% | +$1.86M | ﹤0.01% | 1356 |
|
|
2023
Q3 | $8.9M | Sell |
176,036
-88,390
| -33% | -$4.47M | ﹤0.01% | 914 |
|
|
2023
Q2 | $12.3M | Buy |
264,426
+203,790
| +336% | +$9.51M | ﹤0.01% | 849 |
|
|
2023
Q1 | $2.32M | Buy |
60,636
+26,496
| +78% | +$1.01M | ﹤0.01% | 1872 |
|
|
2022
Q4 | $1.87M | Buy |
34,140
+26,236
| +332% | +$1.44M | ﹤0.01% | 2049 |
|
|
2022
Q3 | $269K | Sell |
7,904
-2,926
| -27% | -$99.6K | ﹤0.01% | 4311 |
|
|
2022
Q2 | $102K | Sell |
10,830
-15,822
| -59% | -$149K | ﹤0.01% | 4734 |
|
|
2022
Q1 | $378K | Sell |
26,652
-3,377
| -11% | -$47.9K | ﹤0.01% | 4051 |
|
|
2021
Q4 | $635K | Buy |
30,029
+5,996
| +25% | +$127K | ﹤0.01% | 3211 |
|
|
2021
Q3 | $538K | Buy |
24,033
+15,353
| +177% | +$344K | ﹤0.01% | 3354 |
|
|
2021
Q2 | $216K | Sell |
8,680
-2,304
| -21% | -$57.3K | ﹤0.01% | 4350 |
|
|
2021
Q1 | $319K | Buy |
+10,984
| New | +$319K | ﹤0.01% | 3849 |
|